INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC

Core Viewpoint - Monteverde & Associates PC is investigating GlycoMimetics, Inc. regarding a proposed merger with First Crescent Biopharma, Inc., which will significantly dilute GlycoMimetics shareholders' ownership in the combined company [1]. Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report and has a successful track record in recovering money for shareholders [1][2]. - The firm is headquartered in the Empire State Building, New York City, and specializes in class action securities litigation [2]. Merger Details - Under the proposed merger agreement, pre-acquisition GlycoMimetics stockholders are expected to own approximately 3.1% of the combined company, while pre-acquisition Crescent stockholders will own approximately 96.9% [1].